Arikayce liposomal Unjoni Ewropea - Malti - EMA (European Medicines Agency)

arikayce liposomal

insmed netherlands b.v. - amikacin sulfate - infezzjonijiet ta 'trap respiratorji - antibatteriċi għal użu sistemiku, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.